Recruiting NCT07332455
First-Time-in-Human Study of GSK5471713 in Adults With mCRPC
Neoplasms, Prostate
Urology
2,917 trials in this section
Recruiting NCT05113537
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Castration-Resistant Prostate Carcinoma · Metastatic Prostate Adenocarcinoma · Stage IV Prostate Cancer AJCC v8
Recruiting NCT05155033
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Metastatic Melanoma · Advanced Locoregional Melanoma · Metastatic Renal Cell Carcinoma
Recruiting NCT06096870
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Prostate Cancer · Recurrent Prostate Cancer · PET Positive
Recruiting NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Prostate Cancer Metastatic
Enrolling by invitation NCT07572227
Fetal Cystoscopy in the Management of Lower Urinary Tract Obstruction (LUTO)
Lower Urinary Tract Obstruction, Congenital
Not yet recruiting NCT07725796
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
Bladder (Urothelial, Transitional Cell) Cancer · NMIBC · Urothelial Carcinoma Bladder
Recruiting NCT07680556
Promoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Oncology
Recruiting NCT06855277
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Not yet recruiting NCT06439784
Contribution of the VERITON-CT Camera in Prostate Bone Radiostereotaxy
Prostatic Cancer
Enrolling by invitation NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive Procedures
Adenocarcinoma · Prostate Neoplasms · Prostate Cancer
Not yet recruiting NCT07725848
Cefepime/Enmetazobactam for Bacteremic Complicated Urinary Tract Infections
Complicated Urinary Tract Infections · Antibiotic Resistance
Recruiting NCT06866964
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Germ Cell Tumor · Testicular Cancer
Recruiting NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Recruiting NCT06161506
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Urinary Urge Incontinence · Stress Urinary Incontinence · Prostatic Hyperplasia
Recruiting NCT07052214
PSMA PET Combined With MRI for the Detection of PCa
PCA · Prostate Cancer · Prostatic Neoplasm
Recruiting NCT07711314
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
Prostate Cancer (Post Prostatectomy)
Enrolling by invitation NCT07724028
Neurovascular Bundle Stimulation During Robot-Assisted Radical Prostatectomy
Histologically Confirmed Localized Prostate Cancer · Scheduled to Undergo Robot-assisted Radical Prostatectomy With Planned Unilateral or Bilateral Nerve-sparing Surgery
Recruiting NCT06907199
Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections
Recurrent UTIs · Cystitis Recurrent
Recruiting NCT06942104
Imaging of Solid Tumors Using 18F-TRX
Solid Tumor · Solid Carcinoma · Castration-Resistant Prostate Carcinoma
Enrolling by invitation NCT07710508
Difference in Incontinence Prevalence Between High Impact Athletes, Low Impact Athletes and Sedentary Subjects
Urinary Incontinence (UI) · Urinary Incontinence , Stress
Recruiting NCT06795087
Discharge Medication Use Post-Operatively in GU Cancer Patients
Genitourinary Cancer
Recruiting NCT07615348
CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
Metastatic Clear Cell Renal Cell Carcinoma
Recruiting NCT07721935
Development of an AI-Agent for Urological Disease Diagnosis and Treatment
Urinary Stones · Prostate Cancer · Bladder Cancer
Recruiting NCT06238713
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
Prostate Adenocarcinoma · Localized Prostate Carcinoma
Recruiting NCT07723378
MISTER Study: Minimally Invasive Steam Therapy - Russian Effectiveness Registry
Benign Prostate Hypertrophy(BPH) · LUTS(Lower Urinary Tract Symptoms)
Recruiting NCT05011383
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Metastatic Prostate Cancer
Not yet recruiting NCT07724158
Target Physiotherapy Versus Exercise Support Intervention for Bladder-bowel Dysfunction in Adolescents With Obesity
Bladder-Bowel Dysfunction · Obesity & Overweight
Recruiting NCT07722884
Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH
Safety · Efficacy · Tamsulosin
Not yet recruiting NCT07724080
Resistance Exercise, IL-7 and Immune Phenotypes in Prostate Cancer
Prostate Cancer · Muscle Loss
Not yet recruiting NCT07716917
Genitourinary Tumors With Sacituzumab Tirumotecan
Papillary Renal Carcinoma · Variant Histology Urothelial Carcinoma
Recruiting NCT00001238
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
Kidney Cancer · Urologic Malignant Disorders · Renal Cell Carcinoma
Recruiting NCT05530655
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
Prostate Cancer · Radiation Toxicity · Urinary Complication
Not yet recruiting NCT07609225
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
Metastatic Castration-resistant Prostate Cancer
Not yet recruiting NCT07723651
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Metastatic Prostate Cancer · Prostate Cancer
Not yet recruiting NCT07577999
The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy
Non-metastatic Bladder Cancer
Recruiting NCT07723248
A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
Metastatic Castration Resistant Prostate Cancer
Not yet recruiting NCT07641855
A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer
Castration-resistant Prostate Cancer
Recruiting NCT06405425
A Study of BL-B01D1 + PD-1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Carcinoma
Recruiting NCT07206225
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Non-muscle Invasive Bladder Cancer
Recruiting NCT07421700
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Urothelial Cancer · Advanced/Metastatic Urothelial Cancer · Urothelial Carcinoma
Not yet recruiting NCT07407673
Prediction and Prevention of Bloodstream Infections After Kidney Transplantation
Kidney Transplant Infection · Bloodstream Infection · Kidney Transplant
Enrolling by invitation NCT06743620
Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Stress Urinary Incontinence
Not yet recruiting NCT07719400
Effects of Pelvic Floor Muscle Training Combined With Bladder Training on Some Parametrs of Men With Urinary Frequency
Urinary Dysfunction
Not yet recruiting NCT07719062
AI Chatbot for Prostate Radiation Therapy Patient Education
Prostate Cancer Patients
Not yet recruiting NCT07095751
Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder Cancer
Bladder Cancer
Recruiting NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC) · Prostatic Neoplasms
Not yet recruiting NCT07720921
Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
Urothelial Carcinoma of the Renal Pelvis and Ureter · Neoadjuvant Therapy
Not yet recruiting NCT07187466
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
Overactive Bladder · Parkinson Disease
Not yet recruiting NCT07719257
Evaluation of the Safety, Tolerability and Pharmacokinetics of TUL108 for Injection in Healthy Participants (SAD/ MAD)
Complicated Urinary Tract Infections(cUTI)
Recruiting NCT06274047
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Androgen Axis Suppression · Prostatectomy · Prostate Cancer
Recruiting NCT06764485
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Recruiting NCT05438563
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
Prostate Carcinoma · Stage I Prostate Cancer AJCC v8 · Stage II Prostate Cancer AJCC v8
Recruiting NCT07720284
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
High-risk Muscle Invasive Urothelial Carcinoma
Recruiting NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Not yet recruiting NCT07278362
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Prostate Cancer · Hypogonadism, Male
Recruiting NCT06168487
Telmisartan in Prostate Cancer
Prostate Cancer
Enrolling by invitation NCT06678828
Clinical Utility of ClarityDX Prostate
Prostate Cancer · Prostate Cancer Screening Decision · Prostate Cancer Screening
Recruiting NCT07302451
REDI-CaP(Recovery of Erectile Dysfunction Induced in Prostate Cancer Patients)
Prostate Cancer (Adenocarcinoma)
Enrolling by invitation NCT04254133
Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
Prostate Carcinoma
Not yet recruiting NCT07201181
Prenatal Tobacco Exposure and Newborn Outcomes: A Maternal Urinary Cotinine Study
Tobacco Smoke Pollution · Maternal Exposure During Pregnancy · Infant, Newborn
Recruiting NCT07426055
PRO-BOOST-LC: Whole-Gland Boost Strategies Versus SBRT Monotherapy in PSMA-Staged Localized and Locally Advanced Prostate Cancer
Prostate Cancer (Adenocarcinoma) · Prostate Brachytherapy · Stereotactic Body Radiation Therapy (SBRT)
Not yet recruiting NCT07717099
Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer
Metastatic Hormone-Sensitive Prostate Cance
Recruiting NCT06111781
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
Prostate Cancer
Recruiting NCT06039371
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Castration-Resistant Prostate Carcinoma · Metastatic Prostate Adenocarcinoma · Stage IVB Prostate Cancer AJCC v8
Recruiting NCT07221825
Low-Count Quantitative SPECT for Men Treated With Radium-223
Prostate Cancer · Cancer of the Prostate
Recruiting NCT07717242
Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer
Bladder Urothelial Carcinoma · Bladder Cancer
Recruiting NCT07207824
DV+BCG in HER2-Expressing, BCG-Naïve High-Risk NMIBC
Bladder (Urothelial, Transitional Cell) Cancer · NMIBC
Recruiting NCT07307456
Toripalimab Combined With BCG Perfusion for the Treatment of HR-NMIBC After TURBT Surgery Exploration
Bladder Cancer
Recruiting NCT07062549
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
Renal Cell Carcinoma (Kidney Cancer)
Recruiting NCT07707232
Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports
Prostate Cancer
Recruiting NCT06094543
Improving Overactive Bladder Treatment Access and Adherence
Overactive Bladder Syndrome · Urinary Incontinence
Recruiting NCT06520345
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Metastatic Castration-resistant Prostate Cancer
Recruiting NCT06952803
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
Recruiting NCT07426094
PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer
Prostate Cancer · Brachytherapy · Stereotactic Body Radiation Therapy (SBRT)
Recruiting NCT07717268
Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.
Prostatic Neoplasms, Castration-Resistant
Not yet recruiting NCT07077083
CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC
Clear Cell Renal Cell Carcinoma (ccRCC) · ccRCC
Not yet recruiting NCT07569874
Thulium Laser Enucleation With Bladder Neck Incision for Small-Volume Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia · Bladder Outlet Obstruction · Lower Urinary Tract Symptoms (LUTS)
Recruiting NCT07543757
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Prostate Cancer Detection
Recruiting NCT07365995
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Metastatic Castration-resistant Prostate Cancer
Not yet recruiting NCT07714018
Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance
Renal Cell Carcinoma (RCC)
Recruiting NCT06150417
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
Prostate Cancer · Malignant Neoplasm of Prostate · Secondary Malignant Neoplasm of Prostate
Not yet recruiting NCT07715565
Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
Renal Cell Carcinoma (Kidney Cancer) · Immunotherapy · Molecular Targeted Therapy
Recruiting NCT07714694
Consumer Evaluation of an Investigational Intermittent Catheter
Urinary Retention · Neurogenic Bladder
Recruiting NCT06549465
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)
PSMA PET-Positive Castration-Resistant Prostate Cancer
Not yet recruiting NCT07714343
Recover@Home Postoperative Follow-up Study
Hernia, Inguinal · Hernia, Femoral · Hernia, Umbilical
Recruiting NCT05833867
Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer
Localized Muscle Invasive Bladder Urothelial Carcinoma · Muscle-Invasive Bladder Carcinoma
Recruiting NCT06378866
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Recurrent Castration-Sensitive Prostate Carcinoma · Recurrent Prostate Cancer · Castration-resistant Prostate Cancer
Recruiting NCT07694752
MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology
Urethral Internal Sphincter Morphology · Benign Prostatic Hyperplasia · Prostate Cancer
Not yet recruiting NCT07634679
Impact of a Bladder Flap on Cesarean Scar Niche Development
Cesarean Scar Defect
Recruiting NCT06380738
Real-World Clinical Experience of Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Olaparib + Abiraterone (PROceed)
Metastatic Castration-resistant Prostate Cancer
Not yet recruiting NCT07518888
Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer
Prostate Cancer
Recruiting NCT05719220
Effect of Group Preoperative Pelvic Floor Training for HoLEP
BPH · Urinary Incontinence
Not yet recruiting NCT07711808
Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled Study
Overactive Bladder (OAB)
Recruiting NCT07222488
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Bladder Cancer · Urinary Bladder Neoplasms
Not yet recruiting NCT07698535
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
Metastatic Castration-Resistant Prostate Adenocarcinoma · Stage IVB Prostate Cancer AJCC v8
Recruiting NCT07456865
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
Urge Urinary Incontinence
Recruiting NCT06067269
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
Prostate Adenocarcinoma · Stage II Prostate Cancer AJCC v8 · Stage IIIA Prostate Cancer AJCC v8
Not yet recruiting NCT07710794
Transcutaneous Tibial Nerve Stimulation (TTNS) Patch in the Treatment of Patients With Lower Urinary Tract Symptoms (LUTS) After Benign Prostatic Hyperplasia (BPH) Surgery
Lower Urinary Tract Symptoms (LUTS) · BPH (Benign Prostatic Hyperplasia)
Recruiting NCT04857502
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
Prostate Carcinoma · Recurrent Prostate Carcinoma